NTAP
56
2
DRI
60
2
COST
63
3
ZTS
25
5
NOV
62
2
KMX
49
2
SWKS
50
4
GT
54
4
SCHW
61
3
WFC
63
-2
APA
48
-4
FRT
53
2
PNR
66
-2
PH
74
4
HBI
30
12
AME
72
6
ROK
42
2
GM
72
6
MUR
52
2
ILMN
36
4
NTAP
56
2
DRI
60
2
COST
63
3
ZTS
25
5
NOV
62
2
KMX
49
2
SWKS
50
4
GT
54
4
SCHW
61
3
WFC
63
-2
APA
48
-4
FRT
53
2
PNR
66
-2
PH
74
4
HBI
30
12
AME
72
6
ROK
42
2
GM
72
6
MUR
52
2
ILMN
36
4
Financhill
Back

BioLife Solutions 10K Form

Sell
43

BLFS
BioLife Solutions

Last Price:
17.17
Seasonality Move:
20.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q BLFS/BioLife Solutions Quarterly
2023-08-09 10Q BLFS/BioLife Solutions Quarterly
2023-05-11 10Q BLFS/BioLife Solutions Quarterly
2022-11-09 10Q BLFS/BioLife Solutions Quarterly
2022-08-09 10Q BLFS/BioLife Solutions Quarterly
2022-05-10 10Q BLFS/BioLife Solutions Quarterly

Receive BLFS News And Ratings

See the #1 stock for the next 7 days that we like better than BLFS

BLFS Financial Statistics

Sales & Book Value

Annual Sales: $143.27M
Cash Flow: $1.33M
Price / Cash Flow: 0
Annual Sales: $7.48
Price / Book: 2.28

Profitability

EPS (TTM): -1.52000
Net Income (TTM): $-66.43M
Gross Margin: $46.75M
Return on Equity: -19.04%
Return on Assets: -15.42%

BioLife Solutions Earnings Forecast

Key BioLife Solutions Financial Ratios

  • The Gross Profit Margin over the past 35 years for BLFS is 32.63%.
  • The Selling, General & Administrative Expenses for BLFS have been equal to 56.05% of Gross Profit Margin.
  • The Research & Development expenses have been 13.12% of Revenue.
  • The Interest Expense is -0.49% of Operating Income.
  • The Net Earning history of BLFS is -46.36% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 15 years.

BioLife Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BLFS
CUSIP: 09062W
Website: biolifesolutions.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 2.86
Quick Ratio: 1.67

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BLFS Technical Analysis vs Fundamental Analysis

Sell
43
BioLife Solutions (BLFS) is a Sell

Is BioLife Solutions a Buy or a Sell?

  • BioLife Solutions stock is rated a Sell
    The current BioLife Solutions [BLFS] share price is $17.02. The Score for BLFS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.